What's happening to Buffett's Tech investment, IBM?! Check out our Report to see our take on its valuation! HIDE

Nektar Therapeutics (NKTR)

Add to Watchlists
Create an Alert
13.25 +0.58  +4.58% NASDAQ Oct 23, 8:00PM BATS Real time Currency in USD
View Full Chart
NKTR Price Chart
View All Events

NKTR Events

Date Type Description
07/31/2014 14:00 PDT Misc Q2 2014 Nektar Therapeutics Inc Earnings Conference Call
07/31/2014 Earnings Q2 2014 Nektar Therapeutics Inc Earnings Results
05/07/2014 17:00 EDT Misc Nektar Therapeutics Inc 1Q2014 Earning Conference Call
05/07/2014 Earnings Nektar Therapeutics Inc 1Q2014 Earning Result
02/26/2014 17:00 EDT Misc Nektar Therapeutics, Inc. Q4 2013 Earning Conference Call
02/26/2014 Earnings Nektar Therapeutics, Inc. Q4 2013 Earning Result
11/07/2013 17:00 EDT Misc Nektar to Announce Financial Results for the Third Quarter Conference Call
11/07/2013 Earnings Nektar to Announce Financial Results for the Third Quarter Earnings Results
View All Performance Charts

NKTR Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Nektar Therapeutics is up 25.83% over the last year vs S&P 500 Total Return up 13.49%, AstraZeneca up 38.76%, and Acorda Therapeutics up 5.42%.

Get Quote for

PDF Report for NKTR

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download NKTR Pro Report PDF
Advertisement

Portfolio Strategies Featuring NKTR

Did Nektar Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

NKTR Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.nektar.com
  • IR Website: http://ir.nektar.com/
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: December 31, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Nektar Therapeutics, Inc., is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients.

NKTR Excel Add-In Codes

  • Name: =YCI("NKTR","name")
  • Description: =YCI("NKTR","description")
  • Sector: =YCI("NKTR","sector")
  • Industry: =YCI("NKTR","industry")
  • Est. Current Fiscal Year End: =YCI("NKTR","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.